Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Pharmaceuticals: Major
Sector Health Technology
Employees 2
CEO Dr. Maria-Luisa Maccecchini
Address 1055 Westlakes Drive Suite 300, Berwyn, PA 19312
Phone 1.610.727.3913
Website www.annovisbio.com

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also develops ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Annovis Bio, Inc. -55.12% 659.49%
Phathom Pharmaceuticals, Inc. -4.95% -4.84%
Nkarta, Inc. 15.91% -4.98%
Stoke Therapeutics, Inc. -23.71% -18.41%
Omeros Corp. 3.24% 55.76%

Statement Summary

as of 4:10 ET PM 09/22/2021
Total Assets (MRQ) 49.5 M
Total Liabilities (MRQ) 884.1 K
Shareholders’ Equity (MRQ) 48.6 M
Total Revenue (Annual) n/a
Net Income (Annual) -2.5 M

Earnings And Estimates

as of 4:10 ET PM 09/22/2021

Current Qtr EPS Estimate -0.38
Current FY EPS Estimate -1.60
Long Term EPS Growth Estimate n/a
Next Expected Earnings Date //

ANVS vs S&P 500

as of 09/22/2021
Relative To
S&P 500
ANVS
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:10 ET PM 09/22/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.37 -0.37 0.00%
03/2021 -0.46 -0.46 0.00%
06/2020 -0.15 -0.15 0.00%

Financial Strength

as of 4:10 ET PM 09/22/2021
Pre-Tax Margin 0.00
Net Margin 0.00
Operating Margin 0.00
Return On Equity -29.03
Return On Assets -28.26
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) n/a

Ratios

as of 4:10 PM ET 09/22/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 5.90
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 6.01
Quick Ratio (MRQ) 55.99
Current Ratio (MRQ) 55.99
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 4:10 PM ET 09/23/2021
% Short - 6.85%
% Remaining Float - 93.15%
Current Last Month
Short Interest Date 08/31/2021 08/13/2021
Short Interest Shares 378,091 711,099
Short Interest Ratio 1.1 0.8
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:10 ET PM 09/22/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.38 $-0.39
# of Estimates 1 1
High Estimate $-0.38 $-0.39
Low Estimate $-0.38 $-0.39
Year Ago EPS $-0.25 $-0.46
Year Over Year Growth Estimate 53.60% -15.64%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-1.60 $-2.57
# of Estimates 1 1
High Estimate $-1.60 $-2.57
Low Estimate $-1.60 $-2.57
Year Ago EPS $-0.87 $-1.60
Year Over Year Growth Estimate 83.91% 60.63%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.38 $-0.39 $-1.60 $-2.57
# of Estimates 1 1 1 1
High Estimate $-0.38 $-0.39 $-1.60 $-2.57
Low Estimate $-0.38 $-0.39 $-1.60 $-2.57
Year Ago EPS $-0.25 $-0.46 $-0.87 $-1.60
Year Over Year Growth Estimate 53.60% -15.64% 83.91% 60.63%

Insider Information Summary

as of 08/31/2021
% Insiders - 31.81%
% Remaining Total Shares - 68.19%
Current 1 Month
Net Insider Transaction 500.00 0.00
Shares Bought 500.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Publisher Meredith Slumps After Posting Weaker Outlook

Meredith Stock Surges on Report of $2.5 Billion IAC Buyout Talks

Meredith soars on a report that it is in acquisition talks with IAC/InterActive Corp.

Nike Store Lead

Nike Stock Lags. Here's When (and Why) to Buy the Dip.

Nike stock is gapping lower on earnings, but major support is close by. Here's what to watch for now.

Cai Hua, the chief executive of Lu International (Hong Kong), which started operations in the city in August this year. Photo: Handout

Goldman Eyes China Chip Stocks; Hua Hong, SG Micro to Conviction List

'Overall, we continue to prefer semiconductors over 5G telecom and smartphone supply chain' in China, Goldman analysts said.

From VR to Food: How Dave & Busters Is Targeting Millennials

Dave & Buster's, Cheesecake Factory Shares Up; Jefferies Likes Risk/Reward

Jefferies analyst Andy Barish upgraded Dave & Buster's and Cheesecake Factory to buy from hold. The shares are higher.

Salesforce Lead

Salesforce Lifts Guidance: What Wall Street Is Saying

Salesforce analysts are bullish on the CRM-software juggernaut after it raised its 2022 revenue guidance.

Video: Jim Cramer on China, Cryptocurrency, Costco, Nike, Debt Ceiling, Semis

Jim Cramer discusses China's crackdown on cryptocurrency, continued debt ceiling talks, Nike, Costco, the chip shortage and more in Friday's video interview with TheStreet Live.

What to know about Cloudflare's Upcoming IPO

Cloudflare Stock Lower; Oppenheimer Eyes Valuation, Competition

Oppenheimer analyst Timothy Horan bases a Cloudflare downgrade on valuation concern and intensifying competition.

Costco Store Lead

Costco Analysts Boost Price Targets After Earnings Beat

Costco analysts raise their price targets after the warehouse-retailing giant beats Wall Street's earnings expectations.

Job Search Lead

US Hiring Surges As COVID Benefits Expire, Supply Chain Hit Bites; Wage Inflation In Focus

Corporate America is hiring seasonal workers to gear up for the annual holiday shopping rush amid concerns of rising inflation and a Fed taper.

Tesla Boss Elon Musk Praises China's 'amazing' Prosperity, Infrastructure As Communist Party Celebrates 100th Birthday

Tesla's Musk Calls Chip Shortage 'Short-Term' Problem

Tesla CEO Musk expects the chip plants soon to come online will render the chip shortage a 'short term' problem.